Skip to content
by Legal Desire
16 July 2024

DLA Piper advises PureTech Health on USD100 million share buy-back

Advising firms

Deal team

3 lawyers named
LawyerFirmSeniorityPracticeOffice
Martin Penn Lead DLA Piper Partner Corporate London
Karin Kirschner DLA Piper Counsel Not stated London
Omefe Uduebor DLA Piper Associate Not stated London

Stated terms

Stated value
USD 100m (USD100 million)
What the figure measures
Total transaction value
Client
PureTech HealthIssuer
Counterparties
Jefferies International (Other)